Cite
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.
MLA
Assmus, Frauke, et al. “Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.” Microorganisms, vol. 10, no. 8, Aug. 2022. EBSCOhost, https://doi.org/10.3390/microorganisms10081639.
APA
Assmus, F., Driouich, J.-S., Abdelnabi, R., Vangeel, L., Touret, F., Adehin, A., Chotsiri, P., Cochin, M., Foo, C. S., Jochmans, D., Kim, S., Luciani, L., Moureau, G., Park, S., Pétit, P.-R., Shum, D., Wattanakul, T., Weynand, B., Fraisse, L., … Chatelain, E. (2022). Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19. Microorganisms, 10(8). https://doi.org/10.3390/microorganisms10081639
Chicago
Assmus, Frauke, Jean-Sélim Driouich, Rana Abdelnabi, Laura Vangeel, Franck Touret, Ayorinde Adehin, Palang Chotsiri, et al. 2022. “Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.” Microorganisms 10 (8). doi:10.3390/microorganisms10081639.